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Abstract
Background: Prognosis assessment of patients with infectious and neoplastic disorders of the central nervous system 
(CNS) may still pose a challenge. In this retrospective cross-sectional study the prognostic value of basic cerebrospinal 
fluid (CSF) parameters in patients with bacterial meningitis, viral meningoencephalitis and leptomeningeal metastases 
were evaluated.
Methods: White blood cell count, CSF/serum glucose ratio, protein, CSF/serum albumin quotient and 
Immunoglobulin indices for IgG, IgA and IgM were analyzed in 90 patients with bacterial meningitis, 117 patients with 
viral meningoencephalitis and 36 patients with leptomeningeal metastases in a total of 480 CSF samples.
Results: In the initial spinal tap, the IgG-index was the only independent predictor for unfavorable outcome (GOS < 5) 
in patients with infectious CNS diseases but not in patients with leptomeningeal metastases. The sensitivity and 
specificity of an IgG-index of 0.75 and higher for predicting unfavorable outcome was 40.9% and 80.8% in bacterial 
meningitis and 40% and 94.8% in viral meningoencephalitis, respectively. No significant associations between CSF 
parameters and outcome could be observed in follow-up CSF samples.
Conclusion: The present study suggests that in infectious CNS diseases an elevated IgG-Index might be an additional 
marker for the early identification of patients at risk for neurological morbidity.
Background
The clinical course of infectious and neoplastic disorders
of the central nervous system is sometimes difficult to
predict. While the diagnosis of bacterial meningitis, viral
meningitis/meningoencephalitis and leptomeningeal
metastases (LM) mainly relies on the analysis of cerebro-
spinal fluid (CSF), only limited data on the prognostic
value of CSF parameters exist [1]. Yet, initial risk assess-
ment of individual patients is of paramount importance
in order to choose the appropriate level of further surveil-
lance (i.e. general ward versus critical care unit) [2]. Of
course, clinical presentation is one of the most important
issues in this respect [3]. This has been shown by differ-
ent authors and complex scores have been developed in
order to raise the predictive accuracy of clinical signs and
symptoms [2,4-7]. In addition, other studies have tried to
assess the role of imaging techniques such as computed
tomography or transcranial Doppler sonography [8,9].
Despite these improvements in clinical and imaging
workup, significance of basic CSF analyses for the early
identification of patients at risk for neurological morbid-
ity has not been sufficiently evaluated. Moreover existing
studies were performed only in one or the other of the
above mentioned disease entities. However, in the early
course of the disease the differential diagnosis of inflam-
matory CNS diseases is not always easy. Therefore this
retrospective study was conducted in order to evaluate
the predictive power of basic CSF parameters obtained by
the initial as well as follow-up spinal taps for disease
prognosis in patient with bacterial meningitis, viral men-
ingitis/meningoencephalitis and LM.
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Methods
Patients
Over a period of 12 years (January 1996 through Septem-
ber 2007) all patients requiring lumbar puncture for dif-
ferential diagnosis of neurological diseases were queried
from the central CSF database of the Department of Neu-
rology. A total of 1675 patients were found. Only patients
with CSF pleocytosis (more than 4 leukocytes/mm3)
showing less than 7000 red blood cells/mm3 were eligible
for further analysis (n = 835). Of these 835 patients, 592
patients had to be excluded due to insufficient data or
inconclusive diagnosis. Finally, 243 patients remained in
the data set. In these patients a total of 480 CSF samples
were collected. Patients were stratified into 3 diagnostic
groups (bacterial meningitis, viral meningoencephalitis,
LM) diagnosed by commonly accepted clinical and/or
microbiological and pathological/cytological criteria [10].
Data collection and outcome measure
The following CSF variables were included in the analy-
ses: white blood cell count (WBC), CSF/serum glucose
ratio (GluR), CSF/serum albumin quotient (Qalb), indices
for IgG, IgA and IgM (IgG-, IgA-, IgM-index representing
the CSF/serum Ig ratio in relation to Qalb) [1]. Intrathe-
cal immunoglobulin synthesis was calculated as
described by Reiber et al. [11]. The neurological outcome
at discharge (Glasgow outcome scale, GOS) was evalu-
ated by chart review. The GOS grades neurological out-
come on a scale from 1 to 5. A score of 1 indicates death;
2, persistent vegetative state (the patient is unable to
interact with the environment); 3, severe disability (the
patient is unable to live independently but can follow
commands); 4, moderate disability (the patient is capable
of living independently but unable to return to work or
school); and 5, mild or no disability (the patient is able to
return to work or school).
GOS was dichotomized to receive binary outcome
measures for logistic regression analyses into unfavorable
outcome (GOS 1-4) and favorable outcome (GOS 5) [12].
All data acquisition was done by purely retrospective
chart review. Subsequent analyses were performed on
anonymized data and therefore institutional review board
approval was waived due to Austrian regulations.
Statistical methods
Patient characteristics were compared between diagnos-
tic groups by ANOVA (age, length of stay (LOS)) or chi-
square test (GOS, sex, confirmed etiology) depending on
the data type and distribution. For outcome analysis a
forward conditional stepwise binary logistic regression
model was calculated using dichotomized GOS as depen-
dent and the respective CSF parameters of the first spinal
tap of each patient as independent variables. Raw data of
all parameters were entered into the model on a non
selective basis. In the stepwise procedure, a significance
level of 0.05 for entering and 0.10 for removing the
respective explanatory variables was set. Age and primary
diagnoses were included as mandatory predictors. In
a d d i t i o n  u n i v a r i a t e  b i n a r y  l o g i s t i c  r e g r e s s i o n  m o d e l s
were calculated of CSF parameters in each patient group.
Finally, multivariate logistic regression models with the
significant predictors of the univariate and the stepwise
procedure as well as age and Qalb as important covariates
were calculated. The levels of the IgG-index in follow-up
CSF samples were analyzed by Wilcoxon signed rank sum
test and p-values were Bonferroni corrected for multiple
comparisons. Sensitivity and specificity of the IgG-index
for unfavorable outcome was determined by drawing
ROC curves and the cut-off value of 0.75 was chosen to
reach maximum specificity. Correlations were calculated
by Spearman's rank correlation. Calculations were done
using PASW 18 (IBM, Chicago, IL, USA). Graphs were
drawn in part with GraphPad Prism 5.00 (GraphPad Soft-
ware, San Diego, CA, USA).
Results
Patients' characteristics
Among 243 patients with inflammatory CSF, 90 patients
were diagnosed with bacterial meningitis, 117 patients
with viral meningoencephalitis and 36 patients with LM,
respectively (table 1).
The etiology was confirmed by microbiology, serology
and/or PCR in 62.2% of the patients with bacterial men-
ingitis and 17.1% of the patients with viral meningoen-
cephalitis (table 1). The most frequent causative
microorganism in bacterial meningitis was Streptococcus
pneumoniae and tick borne encephalitis virus in patients
with viral meningoencephalitis (table 2). LM was diag-
nosed by CSF cytology.
A total of 480 CSF samples were collected. In 95
patients (39.1%) at least two CSF samples were analyzed.
In 39 patients (16.0%) a third CSF sample was available.
The median time gap and interquartile range (IQR)
between the first and second or the second and the third
spinal tap respectively was 5/7 days (IQR 8/6) in patients
with bacterial meningitis, 7/13.5 days (IQR 3/7) in
patients with viral meningoencephalitis and 2/3 days
(IQR 3/5) in patients with LM. These differences were
statistically significant (p < 0.01). The mean age was sig-
nificantly different between groups, being lowest in
patients with viral meningoencephalitis and highest in
patients with LM (p < 0.001, table 1). Length of stay and
percentage of female patients did not differ significantly
between groups (table 1). Outcome, measured by GOS,
showed statistically significant differences between the
patient groups. 94% of the patients with viral meningoen-
cephalitis and 62.2% of the patients with bacterial menin-
gitis but only 13.9% of LM patients showed a full recoveryLackner et al. BMC Infectious Diseases 2010, 10:202
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or only mild neurological deficits at first discharge (p <
0.001, table 1).
Outcome analyses
A stepwise logistic regression model with the dichoto-
mized GOS as dependent and age, primary diagnoses as
well as the respective CSF parameters as independent
variables was calculated. The only CSF parameter show-
ing a significant odds ratio (OR) in this procedure was the
IgG-index. The final model is shown in figure 1. Patients
with bacterial meningitis and LM had an increased risk
for unfavorable outcome as compared to patients with
viral meningoencephalitis. The IgG-index was an inde-
pendent predictor of unfavorable outcome (OR 46.75, CI
2.95-740.14). When including only patients with con-
firmed etiology (n = 112), primary diagnoses and IgG-
index still showed a significant association with outcome
(IgG-Index: OR 25.86, CI 1.31 - 510.64). To further verify
the predictive value of the IgG-index, logistic regression
models for each patient group were calculated (table 3).
In the univariate approach a significant OR for the pre-
diction of unfavorable outcome was found for all immu-
noglobulin indices in viral meningoencephalitis and for
the IgG-index in bacterial meningitis (table 3). In the
multivariate approach besides age, Qalb was included to
correct for blood brain barrier (BBB) dysfunction. In
these models only the IgG-index remained an indepen-
dent predictor of outcome in patients with bacterial men-
ingitis and viral meningoencephalitis but not in patients
with LM. Statistically significant correlations between the
IgG-index and CSF parameters indicating BBB dysfunc-
tion (Qalb and protein) were observed in patients with
bacterial meningitis (Qalb: rho = 0.52, p < 0.001; protein:
rho = 0.54, p < 0.001) and patients with LM (Qalb: rho =
0.39, p = 0.04; protein: rho = 0.60, p = 0.01), but not in
patients with viral meningoencephalitis (Qalb: rho=-0.13,
p = 0.21; protein: rho=-0.05, p = 0.62). The sensitivity and
specificity of an IgG-index of 0.75 and higher to predict
unfavorable outcome was 40.9% and 80.8% in bacterial
meningitis and 40% and 94.8% in viral meningoencephali-
tis, respectively. Intrathecal immunoglobulin synthesis in
patients with an IgG-index of 0.75 and higher was
observed in 26.3% of patients with bacterial meningitis,
55.6% of patients with LM and 100% of patients with viral
meningoencephalitis. Absolute values for intrathecal
immunoglobulin response did not show an association to
outcome. When analyzing only the second spinal tap or
the change of the respective parameters between the first
and second spinal tap no significant association with out-
come could be found. In patients with bacterial meningi-
tis the levels of the IgG-index showed a gradual,
statistically non-significant, decrease in follow up CSF
samples (figure 2). There were no changes of the mean
levels of the IgG-index in LM patients. In patients with
viral meningitis the IgG-index increased in the third CSF
sample however also this difference was not statistically
significant.
Discussion
The current study was conducted to evaluate the prog-
nostic value of basic CSF parameters in patients with bac-
terial meningitis, viral meningoencephalitis and LM. The
only CSF parameter of prognostic significance was the
IgG-index. An IgG-index of 0.75 and higher was found to
Table 1: Patient characteristics
Patient characteristics
characteristic bacterial meningitis viral meningoencephalitis leptomeningeal metastases p
no. of patients 90 117 36
mean age in years (SD) 48.1 (19.5) 39.8 (17) 52.8 (12) p < 0.001
length of stay in days (SD) 19.3 (23) 10.6 (19.4) 17.3 (17.9) p = ns
female patients (%) 41.1 40.3 50 p = ns
GOS (%) p < 0.001
5 (fully independent) 67.8 94 13.9
4 (moderate disability) 15.6 5.1 25
3 (severe disability) 6.7 0 19.4
2 (persistent vegetative state) 2.2 0.9 5.6
1 (dead) 7.8 0 36.1
confirmed etiology (%) 62.2 17.1 100 p < 0.001Lackner et al. BMC Infectious Diseases 2010, 10:202
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be a highly specific predictor of unfavorable outcome in
patients with bacterial and viral meningoencephalitis but
not in patients with LM.
The importance of basic CSF parameters has been
studied in detail and guidelines for the use of routine CSF
analyses in the differential diagnosis of CNS diseases are
available [1]. In this respect the current study gave similar
results. Besides differential diagnosis, risk assessment in
the early phase of diagnostic work-up and therapeutic
management is of paramount importance. In particular
clinical factors like focal neurological deficits and
impaired consciousness but also paraclinical data are of
value [4,6]. However, recent investigations have focused
on risk assessment in patients with only one predefined
diagnosis. In the current multivariate approach, all
patients with inflammatory CSF were analyzed together
including important covariates. Interestingly, besides pri-
mary diagnosis, the IgG-index was the only independent
predictor of unfavorable outcome. In bacterial meningitis
another study showed similar results [13]. Although only
a low number of patients were included in the mentioned
study, patients with neurological morbidity due to bacte-
rial meningitis showed a significantly higher IgG-index in
the initial CSF than patients who fully recovered [13]. In
addition to pathogen virulence, immune mediated mech-
anisms are discussed as important determinants of out-
come in inflammatory CNS disease. Therefore, in
bacterial meningitis early adjunctive administration of
corticosteroids has been suggested. Steroids might sup-
port adrenal insufficiency as well as reduce antimicrobial-
induced inflammatory response [12,14], however a recent
meta-analysis could not show a positive effect on mortal-
ity or morbidity [15]. Hence this adjunctive measure and
in particular its putative effect on the reduction of host
immune response is still not clear and requires further
studies.
While steroid treatment primarily aims at inhibiting
innate immune mechanisms which are certainly most
important in the early phase of bacterial meningitis
[16,17], antibody mediated host response may be detri-
mental as well. This is supported by a recent paper show-
ing early accumulation of dendritic cells in the CSF
during bacterial meningitis which might lead to rapid
induction of adaptive immune mechanisms [18]. There-
fore the observed association of an eleva ted IgG-index
with unfavorable outcome may be explained by second-
ary neuronal damage due to early intrathecal immuno-
globulin reaction. In the current study, IgG-index levels
gradually decreased in patients with bacterial meningitis
during the hospital stay. Furthermore, no association of
CSF parameters with outcome could be observed in fol-
low up CSF samples. These findings support the hypothe-
sis of brain damage by overwhelming host immune
response in the early phase of meningitis. Adaptive
immune response to different pathogens is highly specific
[19] and can certainly not be compared between infec-
tious and neoplastic CNS diseases. In the current study
an elevated IgG-index was an independent predictor of
unfavorable outcome only in patients with infectious
CNS disease but not in the LM group. This could indicate
that specific microorganism-driven immunoglobulin
p r od u ct i o n  is  m o r e  l i k e l y  t o  ca us e  i n fl a m m a t o ry  b r a i n
Table 2: Etiology
Etiology
no. of cases %
BACTERIAL
Streptococcus pneumoniae 25 44.6
Neisseria meningitidis 9 16.1
Mycobacterium tuberculosis 8 14.3
Borrelia burgdorferi 3 5.4
Hemophilus influenzae 3 5.4
Staphylococcus aureus 3 5.4
Streptococcus spp. 3 5.4
Listeria moncytogenes 1 1.8
Multiple microorganisms 1 1.8
VIRAL
Tick borne encephalitis virus 12 60
Varicella Zoster virus 4 20
Cytomegalic virus 1 5
Epstein-Barr virus 1 5
Herpes simplex virus 1 5
Mumps virus 1 5
LM (primary tumor)
Breast cancer 13 36.1
Lung cancer 11 30.6
B-cell lymphoma 3 8.3
Primitive neuroectodermal tumor 2 5.6
B-CLL 1 2.8
Bladder cancer 1 2.8
Glioblastoma multiforme 1 2.8
Multiple myeloma 1 2.8
Renal cell carcinoma 1 2.8
Squamous cell carcinoma 1 2.8
AML 1 2.8Lackner et al. BMC Infectious Diseases 2010, 10:202
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damage resulting in neurological morbidity than
r e s p o n s e  t o  n e o p l a s t i c  c e l l s  i n  L M  [ 2 0 ] .  H o w e v e r ,  t h e
association of an elevated IgG-index with unfavorable
outcome could also be explained as an unspecific epiphe-
nomenon of brain damage. Yet the exact pathomecha-
nisms remain elusive and require further studies.
The current study shows that an elevated IgG-index
predicts unfavorable outcome in patients with bacterial
and viral meningoencephalitis but not in patients with
LM. In patients with bacterial meningitis blood brain bar-
rier damage is immanent. An elevated IgG-index in these
patients could at least in part be attributable to BBB dis-
ruption. This is supported by the observed correlation
between the IgG-index and Qalb and total CSF protein.
However such correlations were not observed in patients
with viral meningoencephalitis in whom the OR and the
specificity of an elevated IgG-index for the prediction of
unfavorable outcome were even higher than in bacterial
meningitis. This suggests that an elevated value for IgG in
CSF is associated with bad outcome irrespective of BBB
integrity.
It should be noted that the average time to result for
immunoglobulin indices with modern analyzers is well
b e l o w  h a l f  a n  h o u r .  T h e r e f o r e  t h i s  r a p i d  t e s t  i s  e a s i l y
applicable in the emergency setting and the current data
s u g g e s t s  t h a t  p a t i e n t s  w i t h  a n  I g G - i n d e x  o f  0 . 7 5  a n d
above at initial presentation should receive special atten-
tion.
Like in every retrospective investigation, also the cur-
rent data has shortcomings which have to be kept in mind
when interpreting the results. Primary etiology was not
confirmed in some patients with bacterial meningitis. In
patients with viral meningoencephalitis the percentage
with confirmed etiology was low compared to reports by
others [21]. This is most likely attributed to the fact that
patients with viral meningitis, who are quickly recover-
ing, are not routinely followed-up serologically at the
study hospital due to the lack of therapeutic conse-
Table 3: Outcome analyses
Prediction of unfavorable outcome (GOS < 5)
bacterial meningitis viral meningo-encephalitis leptomeningeal metastases
Univariate Models
OR (CI) p-value OR (CI) p-value OR (CI) p-value
leukocyte count 0.999 (0.999-1.000) 0.061 0.998 (0.992-1.003) 0.551 0.998 (0.996-1.000) 0.147
GluR 0.664 (0.193-2.282) 0.516 0.166 (0.003-8.677) 0.374 0.023 (0.000-21.15) 0.280
protein 0.999 (0.998-1.000) 0.560 1.006 (0.989-1.023) 0.460 1.000 (0.998-1.002) 0.841
Qalb 1.002 (0.991-1.013) 0.674 1.067 (0.988-1.152) 0.095 1.002 (0.986-1.019) 0.761
IgM-index 0.927 (0.178-4.818) 0.929 14.71 (1.020-212.0) 0.048 0.800 (0.028-22.20) 0.896
IgA-index 1.902 (0.190-19.02) 0.584 655.4 (2.56-167554) 0.022 0.751 (0.015-37.38) 0.886
IgG-index 111.1 (1.876-6587) 0.024 539.8 (3.605-80821) 0.014 1.371 (0.097-19.20) 0.815
Multivariate Model
OR (CI) p-value OR (CI) p-value OR (CI) p-value
age 1.004 (0.974-1.034) 0.801 1.015 (0.965-1.069) 0.565 0.970 (0.882-1.067) 0.529
Qalb 0.995 (0.981-1.009) 0.547 1.084 (0.993-1.184) 0.071 1.000 (0.984-1.017) 0.680
IgG-index 182.1 (1.6-20143) 0.030 767.6 (3.5-167197) 0.016 1.3 (0.114-15.806) 0.816
Figure 1 Outcome analyses. Risk for unfavorable outcome (GOS < 5). 
Odds ratios with confidence interval from a logistic regression model 
are shown (leptomeningeal metastases, LM). Patients with bacterial 
meningitis and LM showed an increased risk for unfavorable outcome 
compared to patients with viral meningoencephalitis. The IgG-index 
was an independent predictor for unfavorable outcome (OR 46.75, CI 
2.95-740.14).
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0.1 1
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quences and economic reasons. In these patients clinical
presentation, laboratory values and also CSF analyses
influenced the final diagnosis. Due to this potential a-pri-
ori selection bias we have computed regression models
including only patients with confirmed etiology. The
results were comparable, though the statistical power was
lower due to the lower number of cases. Therefore we are
convinced that the results of this study are reliable.
Conclusion
In conclusion, an elevated IgG-Index might be added to
the list of markers for the early identification of patients
at high risk for neurological morbidity in infectious CNS
diseases. Further prospective studies are warranted to
verify the present findings and to evaluate the prognostic
potential of the IgG-index in combination with other
clinical and laboratory data.
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